Skip to main navigation Skip to search Skip to main content

GORE®TAG®conformable thoracic stent graft for the treatment of descending aortic pathologies

Research output: Contribution to journal › Article › peer-review

Abstract

Endovascular repair of the descending thoracic aorta has gained widespread acceptance as a primary treatment modality for thoracic aortic disease due to its minimally invasive approach and improved survival rates. GORE® TAG® Conformable Thoracic Stent Graft was designed for descending thoracic aortic aneurysms, penetrating ulcers, aortic transections and type B aortic dissections, which are accepted indications for endovascular therapy. The aim of this review is to summarize the clinical literature, focusing mainly on the publications that came from manufacturer's pre-market and post-market studies. Including the Global Registry for Endovascular Aortic Treatment (GREAT), sponsored by WL Gore & Associates (Flagstaff, AZ, USA), which is a large database of endovascular repair of various thoracic, abdominal and thoraco-abdominal aortic pathologies to identify and evaluate only those with isolated thoracic aortic pathology (arch and descending thoracic).

Original languageEnglish
Pages (from-to)431-441
Number of pages11
JournalFuture Cardiology
Volume18
Issue number5
DOIs
StatePublished - May 2022

ASJC Scopus subject areas

  • Molecular Medicine
  • Cardiology and Cardiovascular Medicine

Keywords

  • GORETAGConformable Thoracic Stent Graft Aortic
  • GORETAGConformable Thoracic Stent Graft with Active Control System
  • GREAT and SURPASS
  • Type B aortic dissection
  • aortic aneurysm
  • arch pathologies
  • endograft
  • thoracic endovascular aortic repair
  • vascular surgical procedure

Fingerprint

Dive into the research topics of 'GORE®TAG®conformable thoracic stent graft for the treatment of descending aortic pathologies'. Together they form a unique fingerprint.

Cite this